1. Home
  2. MRVI vs LTBR Comparison

MRVI vs LTBR Comparison

Compare MRVI & LTBR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MRVI
  • LTBR
  • Stock Information
  • Founded
  • MRVI 2014
  • LTBR 1992
  • Country
  • MRVI United States
  • LTBR United States
  • Employees
  • MRVI 560
  • LTBR N/A
  • Industry
  • MRVI Biotechnology: Pharmaceutical Preparations
  • LTBR Professional Services
  • Sector
  • MRVI Health Care
  • LTBR Consumer Discretionary
  • Exchange
  • MRVI Nasdaq
  • LTBR Nasdaq
  • Market Cap
  • MRVI 350.1M
  • LTBR 397.8M
  • IPO Year
  • MRVI 2020
  • LTBR N/A
  • Fundamental
  • Price
  • MRVI $2.42
  • LTBR $15.13
  • Analyst Decision
  • MRVI Hold
  • LTBR
  • Analyst Count
  • MRVI 10
  • LTBR 0
  • Target Price
  • MRVI $5.84
  • LTBR N/A
  • AVG Volume (30 Days)
  • MRVI 1.5M
  • LTBR 1.5M
  • Earning Date
  • MRVI 08-11-2025
  • LTBR 08-11-2025
  • Dividend Yield
  • MRVI N/A
  • LTBR N/A
  • EPS Growth
  • MRVI N/A
  • LTBR N/A
  • EPS
  • MRVI N/A
  • LTBR N/A
  • Revenue
  • MRVI $219,830,000.00
  • LTBR N/A
  • Revenue This Year
  • MRVI N/A
  • LTBR N/A
  • Revenue Next Year
  • MRVI $7.23
  • LTBR N/A
  • P/E Ratio
  • MRVI N/A
  • LTBR N/A
  • Revenue Growth
  • MRVI N/A
  • LTBR N/A
  • 52 Week Low
  • MRVI $1.67
  • LTBR $2.24
  • 52 Week High
  • MRVI $9.60
  • LTBR $18.80
  • Technical
  • Relative Strength Index (RSI)
  • MRVI 49.60
  • LTBR 52.17
  • Support Level
  • MRVI $2.28
  • LTBR $12.93
  • Resistance Level
  • MRVI $2.47
  • LTBR $16.19
  • Average True Range (ATR)
  • MRVI 0.14
  • LTBR 1.48
  • MACD
  • MRVI -0.01
  • LTBR -0.02
  • Stochastic Oscillator
  • MRVI 27.45
  • LTBR 37.48

About MRVI Maravai LifeSciences Holdings Inc.

Maravai LifeSciences Holdings Inc is a life sciences company that provides critical products that drive the development of groundbreaking vaccines, drug therapies, cell and gene therapies, and diagnostics. The group's solutions empower research into human diseases and support the entire biopharmaceutical development process from early discovery to commercialization. Its reportable segments are Nucleic acid production and biologics safety testing. It generates a majority of its revenue from Nucleic Acid Production and focuses on the manufacturing and sale of nucleic acid products to support the needs of customers' research, and therapeutic and vaccine programs. In addition, the segment also provides research products for labeling and detecting proteins in cells and tissue samples.

About LTBR Lightbridge Corporation

Lightbridge Corp is a United States-based nuclear fuel technology company. The business activity of the firm is functioned through one business segment, which is the development and commercialization of its nuclear fuel. The Nuclear Fuel Technology segment develops next generation nuclear fuel technology that increases the power output of commercial reactors and reduces the cost of generating electricity. Geographically, its operations are functioned through the region of Unites States.

Share on Social Networks: